Contact this trialFirst, we need to learn more about you.
Vaccine
Combination Immunotherapy for Non-Hodgkin Lymphoma
Recruiting2 awardsPhase 1 & 2
Rochester, Minnesota
This trial tests a combination of a personalized vaccine, a freezing technique to kill cancer cells, and an immune-boosting drug in patients with non-Hodgkin lymphoma. The goal is to improve treatment effectiveness by enhancing the immune response and directly targeting cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.